The altered expression of COX7C in our study suggests that impaired energy metabolism may be a key factor in T2D-related MCI, potentially offering a target for therapeutic interventions aimed at improving mitochondrial function. The gene discussed is COX7C; the disease is type 2 diabetes mellitus.